BXT-51072 blocker of free radicals and reactive oxygen: OXIS began Phase I testing in the U.K.

Oxis International Inc. (OXIS), Portland, Ore. Product: BXT-51072 blocker of free radicals and reactive oxygen Indication: Diseases involving oxidative stress Status: OXIS began Phase I testing in th...